BUILDING BETTER BIOTECHS

Serial Number 98710009
Registration 7793840
700

Registration Progress

Application Filed
Aug 21, 2024
Under Examination
Approved for Publication
Mar 25, 2025
Published for Opposition
Mar 25, 2025
Registered
May 13, 2025

Trademark Image

BUILDING BETTER BIOTECHS

Basic Information

Serial Number
98710009
Registration Number
7793840
Filing Date
August 21, 2024
Registration Date
May 13, 2025
Published for Opposition
March 25, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
May 13, 2025
Registration
Registered
Classes
035

Rights Holder

SSI Strategy LLC

16
Address
9 Campus Drive, Suite 103
Parsippany, NJ 07054

Ownership History

SSI Strategy LLC

Original Applicant
16
Parsippany, NJ

SSI Strategy LLC

Owner at Publication
16
Parsippany, NJ

SSI Strategy LLC

Original Registrant
16
Parsippany, NJ

Legal Representation

Attorney
Jason H. Kasner

USPTO Deadlines

Next Deadline
1964 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20250513)
Due Date
May 13, 2031
Grace Period Ends
November 13, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

9 events
Date Code Type Description Documents
May 13, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
May 13, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Mar 25, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 25, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 19, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 27, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 26, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 17, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 21, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 035
Business consulting, management, and planning services in the field of Pharmaceuticals, Biotechnology, Medical Devices, Life Sciences, Medical Affairs, Pharmacovigilance, Clinical Development
First Use Anywhere: Jun 20, 2024
First Use in Commerce: Jun 20, 2024

Classification

International Classes
035